erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Otitis Externa D010032 8 associated lipids
Rhabdomyolysis D012206 9 associated lipids
Tachycardia, Ventricular D017180 9 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Bacteremia D016470 9 associated lipids
Urethritis D014526 9 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Tooth, Impacted D014095 9 associated lipids
Obstetric Labor, Premature D007752 9 associated lipids
Otitis Media with Effusion D010034 9 associated lipids
Sinusitis D012852 9 associated lipids
Cross Infection D003428 9 associated lipids
Cleft Palate D002972 9 associated lipids
Osteitis D010000 10 associated lipids
Nephritis, Interstitial D009395 10 associated lipids
Osteomyelitis D010019 10 associated lipids
Rhinitis D012220 10 associated lipids
Long QT Syndrome D008133 10 associated lipids
Respiratory Insufficiency D012131 10 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Dermatitis, Seborrheic D012628 10 associated lipids
Hearing Disorders D006311 10 associated lipids
Pancreatitis D010195 10 associated lipids
Abnormalities, Drug-Induced D000014 10 associated lipids
Dyspnea D004417 10 associated lipids
Lung Diseases, Obstructive D008173 10 associated lipids
Pneumonia D011014 10 associated lipids
Sepsis D018805 11 associated lipids
Scalp Dermatoses D012536 11 associated lipids
Urinary Tract Infections D014552 11 associated lipids
Hyperbilirubinemia D006932 11 associated lipids
Skin Neoplasms D012878 12 associated lipids
Wound Infection D014946 12 associated lipids
Crohn Disease D003424 12 associated lipids
Eye Diseases D005128 12 associated lipids
Otitis Media D010033 12 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Death, Sudden D003645 12 associated lipids
Death, Sudden, Cardiac D016757 12 associated lipids
Endophthalmitis D009877 12 associated lipids
Listeriosis D008088 12 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Urticaria D014581 13 associated lipids
Critical Illness D016638 13 associated lipids
Hematuria D006417 13 associated lipids
Corneal Diseases D003316 13 associated lipids
Airway Obstruction D000402 13 associated lipids
Rosacea D012393 13 associated lipids
Multiple Myeloma D009101 13 associated lipids
Mycoplasma Infections D009175 13 associated lipids
Campylobacter Infections D002169 13 associated lipids
Pain, Postoperative D010149 13 associated lipids
Abscess D000038 13 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Bradycardia D001919 13 associated lipids
Uveitis D014605 14 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Stomatitis D013280 14 associated lipids
Tremor D014202 15 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
HIV Seropositivity D006679 15 associated lipids
Neutropenia D009503 15 associated lipids
Synovitis D013585 15 associated lipids
Cholelithiasis D002769 16 associated lipids
Choline Deficiency D002796 16 associated lipids
Blister D001768 16 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Liver Cirrhosis, Alcoholic D008104 17 associated lipids
Ischemia D007511 18 associated lipids
Tuberculosis, Pulmonary D014397 18 associated lipids
Leukemia, Lymphoid D007945 18 associated lipids
Leishmaniasis D007896 19 associated lipids
Hypothermia D007035 19 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Pleurisy D010998 20 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Ataxia D001259 20 associated lipids
Tuberculosis D014376 20 associated lipids
Gastrointestinal Diseases D005767 20 associated lipids
Vomiting D014839 21 associated lipids
Bacterial Infections D001424 21 associated lipids
Periodontitis D010518 22 associated lipids
Hypersensitivity D006967 22 associated lipids
Cholestasis D002779 23 associated lipids
Birth Weight D001724 23 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Nasal Polyps D009298 26 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Obesity D009765 29 associated lipids
Drug Eruptions D003875 30 associated lipids
Dermatitis D003872 30 associated lipids
Liver Diseases D008107 31 associated lipids
Cardiomegaly D006332 31 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Li YX et al. Sensitive determination of erythromycin in human plasma by LC-MS/MS. 1998 J Pharm Biomed Anal pmid:9547699
Bertho G et al. Transferred nuclear Overhauser effect study of macrolide-ribosome interactions: correlation between antibiotic activities and bound conformations. 1998 Bioorg. Med. Chem. pmid:9547944
Tanaka E and Breimer DD In vivo function tests of hepatic drug-oxidizing capacity in patients with liver disease. 1997 J Clin Pharm Ther pmid:9548204
Sachdeo RC et al. Evaluation of the potential interaction between felbamate and erythromycin in patients with epilepsy. 1998 J Clin Pharmacol pmid:9549651
Chakrabarti MK et al. Evaluation of different antibiotics in inhibiting colonization of Vibrio cholerae O1 and O139 in the rabbit intestine. 1998 Mar-Apr Chemotherapy pmid:9551241
Mück W et al. Influence of erythromycin pre- and co-treatment on single-dose pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin. 1998 Eur. J. Clin. Pharmacol. pmid:9551706
Mortensen JE et al. In vitro activity of oral antimicrobial agents against clinical isolates of Pasteurella multocida. 1998 Diagn. Microbiol. Infect. Dis. pmid:9554176
Schwarz MI A man with dyspnea, productive cough, and chest radiograph showing hyperinflation and a diffuse nodular pattern. 1998 Chest pmid:9554657
Lilley LL and Guanci R Drug interaction triggers weakness. 1998 Am J Nurs pmid:9556673
Konturek JW and Domschke W [Gastroparesis--physiopathology, diagnosis and the latest therapy]. 1998 Dtsch. Med. Wochenschr. pmid:9556697
Shah F Erythromycin. 1998 Pediatr Rev pmid:9557068
Ross JI et al. Resistance to erythromycin and clindamycin in cutaneous propionibacteria is associated with mutations in 23S rRNA. 1998 Dermatology (Basel) pmid:9557230
Cleary RK et al. Metronidazole may inhibit intestinal colonization with Clostridium difficile. 1998 Dis. Colon Rectum pmid:9559631
Rutman A et al. Effect of dirithromycin on Haemophilus influenzae infection of the respiratory mucosa. 1998 Antimicrob. Agents Chemother. pmid:9559781
Barry AL et al. Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin). 1998 Antimicrob. Agents Chemother. pmid:9559816
Roblin PM and Hammerschlag MR In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae. 1998 Antimicrob. Agents Chemother. pmid:9559818
Hoppe JE and Bryskier A In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine). 1998 Antimicrob. Agents Chemother. pmid:9559823
Garcia-Bermejo I et al. Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain. 1998 Antimicrob. Agents Chemother. pmid:9559831
Mitsuyama T et al. Release of nitric oxide and expression of constitutive nitric oxide synthase of human endothelial cells: enhancement by a 14-membered ring macrolide. 1998 Mol. Cell. Biochem. pmid:9562252
Kieran E et al. Group B streptococcus (GBS) colonisation among expectant Irish mothers. 1998 Jan-Feb Ir Med J pmid:9563251
Salah-Bey K et al. Targeted gene inactivation for the elucidation of deoxysugar biosynthesis in the erythromycin producer Saccharopolyspora erythraea. 1998 Mol. Gen. Genet. pmid:9563840
Jamkhedkar PP et al. Clinico-epidemiologic features of granuloma inguinale in the era of acquired immune deficiency syndrome. 1998 Sex Transm Dis pmid:9564722
Delgado LF et al. Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children. 1998 Ann. Allergy Asthma Immunol. pmid:9564984
Riley RJ and Howbrook D In vitro analysis of the activity of the major human hepatic CYP enzyme (CYP3A4) using [N-methyl-14C]-erythromycin. 1997 J Pharmacol Toxicol Methods pmid:9566442
Andrews PA Interactions with ciprofloxacin and erythromycin leading to aminophylline toxicity. 1998 Nephrol. Dial. Transplant. pmid:9568870
Roark GA Guest clinician: an alternative treatment of RAU (recurrent apthous ulcers). 1996 Miss Dent Assoc J pmid:9571920
Juanqin G et al. Evaluation of the effectiveness of childhood generalized pustular psoriasis treatment in 30 cases. 1998 Mar-Apr Pediatr Dermatol pmid:9572705
Elliott RL et al. Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues. 1998 J. Med. Chem. pmid:9572890
Griesgraber G et al. Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues. 1998 J. Med. Chem. pmid:9572891
Stephenson GA et al. Formation of isomorphic desolvates: creating a molecular vacuum. 1998 J Pharm Sci pmid:9572901
Piccolomini R et al. In vitro antimicrobial susceptibility of periodontopathic Actinobacillus actinomycetemcomitans to roxithromycin and erythromycin. 1997 Oral Microbiol. Immunol. pmid:9573812
Higa F et al. Simplified quantitative assay system for measuring activities of drugs against intracellular Legionella pneumophila. 1998 J. Clin. Microbiol. pmid:9574712
Hoppe JE Susceptibility testing of Bordetella pertussis. 1998 J. Clin. Microbiol. pmid:9574735
Bassotti G et al. Effect of different doses of erythromycin on colonic motility in patients with slow transit constipation. 1998 Z Gastroenterol pmid:9577904
Ednie LM et al. Anti-anaerobic activity of erythromycin, azithromycin and clarithromycin: effect of pH adjustment of media to compensate for pH shift caused by incubation in CO2. 1998 J. Antimicrob. Chemother. pmid:9578166
Brett M et al. The comparative in-vitro activity of roxithromycin and other antibiotics against Bordetella pertussis. 1998 J. Antimicrob. Chemother. pmid:9579709
Malizia T et al. Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study. 1998 J. Antimicrob. Chemother. pmid:9579710
Bouvier d'Yvoire MJ et al. Computer-aided prediction of macrolide antibiotic concentrations in human circulating polymorphonuclear leucocytes. 1998 J. Antimicrob. Chemother. pmid:9579715
Bertho G et al. Solution conformation of methylated macrolide antibiotics roxithromycin and erythromycin using NMR and molecular modelling. Ribosome-bound conformation determined by TRNOE and formation of cytochrome P450-metabolite complex. 1998 Int. J. Biol. Macromol. pmid:9585888
Boiron M et al. Erythromycin elicits opposite effects on antro-bulbar and duodenal motility: analysis in diabetics by cineradiography. 1997 Arch. Physiol. Biochem. pmid:9587651
Wieteska M [Legionnaires' diseases]. 1998 Pol. Merkur. Lekarski pmid:9591446
Goldstein EJ et al. Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans. 1998 Antimicrob. Agents Chemother. pmid:9593139
Spangler SK et al. Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci. 1998 Antimicrob. Agents Chemother. pmid:9593160
Dodhia H and Miller E Review of the evidence for the use of erythromycin in the management of persons exposed to pertussis. 1998 Epidemiol. Infect. pmid:9593483
de Bethune MP and Nierhaus KH Characterisation of the binding of virginiamycin S to Escherichia coli ribosomes. 1978 Eur. J. Biochem. pmid:95947
Hoover J "Antibiotic selection for endodontic infections". 1995 J Gt Houst Dent Soc pmid:9594808
Sakata K et al. [Effects of macrolide antibiotics to inhibit infiltration and proliferation of malignant tumor cells--in vitro evaluation]. 1997 Jpn J Antibiot pmid:9597435
Ieshiro R et al. [Effect of clarithromycin in extending the life expectancy of patients with non-small-cell lung cancer]. 1997 Jpn J Antibiot pmid:9597440
Nakada J et al. [Effects of erythromycin and roxithromycin on airway goblet cell secretion]. 1997 Jpn J Antibiot pmid:9597441
Suzuki H et al. [Il-8 secretion by cultured epithelial cells of human nasal mucosa and its suppression by macrolide antibiotics]. 1997 Jpn J Antibiot pmid:9597442